Effect of latanoprost on outflow facility in the mouse

Invest Ophthalmol Vis Sci. 2004 Jul;45(7):2240-5. doi: 10.1167/iovs.03-0990.

Abstract

Purpose: To assess the early effect of latanoprost on outflow facility and aqueous humor dynamics in the mouse.

Methods: Aqueous humor dynamics in NIH Swiss White mice were assessed with an injection and aspiration system, using fine glass microneedles. A single 200-ng (4 microL) dose of latanoprost was applied to one eye 2 hours before measurement. The fellow eye served as a control. Intraocular pressure (IOP) was measured by using an established microneedle procedure. Outflow facility (C) was determined by constant-pressure perfusion measurements obtained at two different IOPs. Aqueous humor flow (Fa) was determined by a dilution method using rhodamine-dextran. Conventional and uveoscleral outflow (Fc and Fu) were calculated by the Goldmann equation.

Results: Average IOP, Fa, and C of control eyes were 15.7 +/- 1.0 mm Hg, 0.144 +/- 0.04 microL/min (mean +/- SD, n = 8), and 0.0053 +/- 0.0014 microL/min per mm Hg (n = 21), respectively. Average IOP, Fa, and C of treated eyes were 14.0 +/- 0.8 mm Hg, 0.138 +/- 0.04 microL/min (n = 8 for each), and 0.0074 +/- 0.0016 microL/min per mm Hg (n = 21), respectively. The differences between treated and control eyes were significant for IOP and total outflow facility only.

Conclusions: These data indicate that the early hypotensive effect of latanoprost in the mouse eye is associated with a significant increase in total outflow facility. Alterations in the aqueous dynamics induced by latanoprost can be measured reproducibly in the mouse and may provide a useful model for further determining the mechanism by which latanoprost reduces IOP and alters outflow facility.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antihypertensive Agents / pharmacology*
  • Aqueous Humor / metabolism*
  • Intraocular Pressure / drug effects*
  • Latanoprost
  • Mice
  • Prostaglandins F, Synthetic / pharmacology*
  • Sclera / metabolism
  • Trabecular Meshwork / drug effects*
  • Trabecular Meshwork / metabolism
  • Uvea / metabolism

Substances

  • Antihypertensive Agents
  • Prostaglandins F, Synthetic
  • Latanoprost